Source: Annual Congress 2010 - New insights in the pathology of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Ruppert, O. Bianchi, P. Souza, E. R. Parra, G. Noleto, M. Atanazio, A. Ab´Saber, W. Teodoro, T. Takagaki, N. Yoshinari, V. L. Capelozzi (Brazil). Down regulation of type V collagen triggers angiogenesis and immune response disfunction in lung cancer microenvironment. Eur Respir J 2010; 36: Suppl. 54, 5166

Member's Comments

No comment yet.

Related content which might interest you: Refractory remodelling of the microenvironment by type V collagen and apoptosis in non small cell lung cancer Source: Annual Congress 2009 - Pathogenesis of lung cancer Year: 2009 Nasal tolerance promotes increase in tumoral type V collagen protein synthesis and vascular apoptosis in the mouse lung chemical carcinogenesis Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 RANKL contributes to lung tissue repair via promoting type II epithelial cell proliferation Source: Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro Year: 2020 PP126 – RANKL contributes to lung tissue repair via promoting type II epithelial cell proliferation Source: ERS Lung Science Conference 2021 Year: 2021 Circulating fibrocytes depletion results in reduced lung tumor growth and metastasis by modulating macrophage phenotype, angiogenesis and endothelin system Source: ERS Lung Science Conference 2017 Year: 2017 c-Met expression induction in immune cells modulates pulmonary fibrosis progression Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 Collagen V nasal tolerance reverts pulmonary immune cells proliferation and interstitium remodeling in experimental scleroderma Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Inhibition of insulin-like growth factor type I (IGF-I) gene in A549 human lung cancer cell line enhances cell apoptosis and causes phenotype changes relevant to increased tumor susceptibility to immune system Source: Eur Respir J 2007; 30: Suppl. 51, 715s Year: 2007 Inhibition of osteopontin modulates tumor-stimulated immune response and suppresses mesothelioma progression Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012 Low apoptosis rate as a reason of local immune cell accumulation in interstitial lung diseases (ILD). The role of cytokine network Source: Eur Respir J 2006; 28: Suppl. 50, 826s Year: 2006 From ineffective tumor immune response to immunomodulation in lung cancer Source: ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies? Year: 2017 Interleukin-17 enhances the net angiogenic potential and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis Source: Eur Respir J 2004; 24: Suppl. 48, 79s Year: 2004 LSC Abstract – High mobility group box 1 modulates lung innate immunity by promoting wound healing and cytokine release in human bronchial epithelial cells Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015 Type V collagen and endothelial apoptosis interface in non small cell lung cancer has impact on prognosis Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Composition of the cellular matrix, nutrition, and hypoxia modulate the secretion and activation of collagenases and their inhibitors in human lung cells Source: Eur Respir J 2001; 18: Suppl. 33, 244s Year: 2001 Oral presentation: Altered airway epithelial gene expression determines the lung remodeling response to environmental allergens; role of activin Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung Year: 2010 The role of epithelial Pten in programmed cellular senescence during lung development Source: International Congress 2018 – Molecular and cellular determinants of the developing lung Year: 2018 Regulation of human adult primary alveolar type II cell surfactant protein production by epithelial growth factors and pro-inflammatory cytokines Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation Year: 2009 Nintedanib inhibits pro-fibrotic mediators from T cells with relevance to connective tissue disease-associated interstitial lung disease Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017